PON1 and gestational diabetes: GDM-HDL oxidised 55% of DHR, and after treatment with Darapladib oxidation increased to 64% (p < 0.001); inhibition of PON-1 also led to an increase in oxidation up to 64% (p < 0.001, Fig. 8c).